What is benign MS? Does it even exist? Certainly it is not one of the types of the disease often listed as making up the multiple sclerosis family.
It is a term that is surrounded by controversy, not least among neurologists […]
News that daclizumab, brand name Zinbryta, has been given the go-ahead to be available through the U.K.’s National Health Service (NHS) for treating relapsing MS, at least in part of the country, is good news. But why has the decision taken […]Read More
We all know, because we have heard it so many times, that MS is not the same for everyone — that no two people have exactly the same combination of symptoms.
That got me thinking the other day (pause for call-outs […]
There is now less than a month until the U.S. Food and Drug Administration (FDA) is expected to approve Ocrevus, generic name ocrelizumab, for use as a therapy for multiple sclerosis.
Clinical trials have shown Genentech’s drug to be a promising […]
It was a trip, plain and simple, neither my leg giving way nor a fall. It was MS-related because it was directly caused by foot drop; the toe of my left shoe caught on the tiniest ridge at the bottom […]Read More